Time Post-Dose
|
LAMA, n = 15
|
uLABA, n = 16
|
Combo, n = 14
|
---|
1 h
|
100% (15/15)
|
62.5% (10/16)
|
100% (14/14)
|
24 h
|
73.3% (11/15)
|
37.5% (6/16)
|
64.3% (9/14)
|
48 h
|
80% (12/15)
|
18.8% (3/16)
|
64.3% (9/14)
|
- LAMA, long-acting muscarinic antagonist; uLABA, ultra-long acting β2 agonist; Combo, combination therapy